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of thyroid nodule evaluation by 
implementation of cell block 
preparation in routine US-FNA analysis
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ABSTRACT
Objective: Ultrasound-guided fine-needle aspiration (US-FNA) biopsy has proven to be an accurate 
and efficient tool in thyroid nodule evaluation. We evaluated whether cell block adds to the diagnostic 
accuracy of US-FNA. Subjects and methods: Three hundred twenty-eight consecutive patients 
underwent US-FNA, cytology and cell block evaluation. Six slides were prepared for each patient 
and stained by Papanicolaou and Giemsa techniques. The residual hemorrhagic aspirate 
in the syringe and needle was fixed in 10% formalin and paraffin-embedded (cell block). The 
histological sections were examined as a complementary diagnostic tool to US-FNA. Results: 
The study population comprised 89% females and the mean age was 57.4 ± 13.7 years. The mean 
nodule size was 2.3 ± 1.2 cm. US-FNA cytological results were as follows: Bethesda I, 17.1% 
(n = 56); Bethesda II, 61.6% (n = 202); Bethesda III, 9.5% (n = 31); Bethesda IV, 5.8% (n = 19); 
Bethesda V, 2.4% (n = 8), and Bethesda VI, 3.6% (n = 12). Cell blocks were obtained in 100% 
of cases and were considered diagnostic in 89.6%. Combined cytological and cell block (cyto-cell 
block) results were as follows: unsatisfactory, 4.3% (n = 14); benign, 72.6% (n = 238); indeterminate, 
11.3% (n = 37); follicular lesion, 5.8% (n = 19); suspicious for malignancy, 2.4% (n = 8), and malignant, 
3.6% (n = 12). The sensitivity and specificity for cyto-cell block was 100% and 90%, respectively, 
and the accuracy was 94%. Cyto-cell block analysis reduced the rate of unsatisfactory samples 
(p < 0.001). Conclusions: The cyto-cell block interpretation improved the efficiency of US-FNA. This 
simple, fast and low-cost technique should be used as an adjunctive test in thyroid nodule evaluation. 
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INTRODUCTION
T hyroid nodules are common clinical findings, more frequent in women and in the elderly 
population, while cases of thyroid cancer are relatively 
rare. The current diagnostic method of choice for 
differentiating benign from malignant lesions is the 
fine needle aspiration (FNA) cytology guided by 
ultrasonography (US-FNA) (1-3). This procedure has 
been shown to be superior to clinical, radionucleotide 
or thyroid ultrasound assessment alone (4). Technique 
limitations and its advantages are well established and 
described by several authors (1,5). According to the 
current guidelines of the Brazilian Endocrine Society 
(2013) and the American Thyroid Association (2009), 
when hyperfunctioning or purely cystic nodules have 
been ruled out, US-FNA is a fundamental tool on 
thyroid nodule evaluation (6).
Thyroid carcinoma is the most common endocrine 
tumor of the head and neck region, accounting for around 
5% all cancers in women. The latest global estimate 
indicated the occurrence of about 300.000 new cases 
of this cancer (68.000 in men and 230.000 in women). 
In Brazil, it corresponds to 1.150 new cases of thyroid 
cancer in males and 8.050 in females, with an estimated 
risk of 1.15/100.000 cases in men and 7.91/100.000 
cases in women, according to data recorded by INCA 
(National Cancer Institute) in the year 2014 (7,8). 
In the last years, there has been significant progress 
in the adoption of thyroid US-FNA reporting 
terminology due to international efforts. From the 
Co
py
rig
ht
©
 A
E&
M
 a
ll r
ig
ht
s r
es
er
ve
d.
368
Implementation of cell block in US-FNA routine
Arch Endocrinol Metab. 2016;60/4
deliberations in October 2007 by the National Cancer 
Institute in Bethesda, Maryland, the diagnostic 
categories for thyroid US-FNA were defined following 
the “Bethesda System”. The Bethesda System, consists 
of 6 categories and each has distinct morphological 
characteristics and cancer risk. These guidelines 
facilitate communication between professionals and 
help in the research and diagnosis of thyroid disease. 
Thus, the system allows easy data sharing between 
different laboratories nationally and internationally 
(9). Nevertheless, wide variations are reported in 
the literature in the overall performance of thyroid 
US-FNA as a diagnostic test, which reflect either 
variations in methodology used or variations in criteria 
for reporting of thyroid US-FNA (10).
The US-FNA technique has some inherent 
limitations. First, the US-FNA sample must be evaluated 
for adequacy. Inadequate samples are reported as 
“nondiagnostic” (ND) or “unsatisfactory” (UNS). 
This category applies to specimens that are unsatis-
factory owing to obscuring blood, overly thick smears, 
air drying of alcohol-fixed smears, or an inadequate 
number of follicular cells. ND/UNS results occur in 
2% to 20% of cases but ideally should be limited to no 
more than 10% of thyroid US-FNAs. Furthermore, 
some thyroids US-FNAs are not easily classified into 
the benign, suspicious, or malignant categories. 
Such cases represent a minority of thyroid US-FNAs 
and in the Bethesda System are reported as “atypia 
of undetermined significance” (AUS) or “follicular 
lesion of undetermined significance”. An AUS result is 
obtained in 3% to 6% of thyroid US-FNAs (9). 
Cell blocks are a valuable tool to evaluate various 
cytology specimens and are often prepared with 
US-FNA from multiple organs as an adjunct to smears 
in the diagnosis of aspirated lesions. In addition to 
the architectural details of the specimen, cell blocks 
allow for evaluation by ancillary studies such as 
immunohistochemistry. The cell block technique 
includes the centrifugation of the material aspirated 
from the lesion to decrease cell dispersion of traditional 
cytology smears, which presence of hemorrhage or low 
cellularity sometimes makes the method unsatisfactory 
(10-12). 
The aim of this study was to evaluate the diagnostic 
efficiency of US-FNA followed by processing the 
aspirated material using the cell block technique as part 
of investigation of thyroid nodules by a multidisciplinary 
team in a tertiary, University-based Hospital.
SUBJECTS AND METHODS
Patients
Over a period of 22 months (March 2012 to December 
2013), 559 patients were attended at the Thyroid Unit 
of the Centro de Pronto Diagnóstico Ambulatorial 
(CPDA), Hospital de Clínicas de Porto Alegre (HCPA). 
Two-hundred-one (36%) patients were excluded from 
analysis: 155 (27.7) did not meet criteria for FNA-US 
and 46 had aspirated cervical lymph nodes. A total of 
358 (64%) patients presented with thyroid nodules 
underwent US-FNA procedure were initially included in 
the study. Out of them, 328 (91.6%) patients had their 
samples analyzed by both cyto and cyto-cell while 30 
samples (8.3%) were analyzed only by cytology. Thus, the 
study population consisted of 328 consecutive patients. 
US-FNA, cyto-cell block
All patients underwent thyroid US-FNA performed by 
the same radiologist using a high-resolution ALOKA 
ultrasound device with a 7.5 MHz linear transducer 
(Tokyo, Japan). US-FNA was performed with a 
disposable needle (21 G) connected to a 10 ml disposable 
syringe. The needle tip was identified as a bright spot 
in the monitor and then inserted perpendicularly to 
the cervical region and guided to the aspiration site. 
Constant negative pressure with the syringe plunger 
is maintained until material is seen at the base of the 
needle. Multidirectional aspiration was performed 
in: dominant nodules in patients with multinodular 
goiter, suspicious nodules on ultrasonography or in 
various locations in cases of diffuse goiter. Rapid on-site 
evaluation of fine needle aspiration of all specimens were 
performed to evaluate adequacy. For a thyroid FNA 
specimen to be considered satisfactory, at least 6 groups 
of follicular cells were required, each group composed 
of at least 10 cells (9). Cyst-fluid-only (CFO) cases were 
considered ND/UNS. Immediate on site reaspiration 
was performed in cases considered inadequate for 
diagnosis. Six cytology slides were prepared for each 
patient, four of them air dried and immediately stained 
by May Grünwald Giemsa technique. The other two 
slides were immediately fixed in ethanol 96º and 
subsequently stained by the Papanicolaou technique. 
The residual hemorrhagic aspirate in the syringe and 
needle was fixed in 10% formalin, transferred to a test 
tube and centrifuged at 600 rpm for 30 minutes. The 
pellet obtained after centrifugation was transferred to 
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absorbent paper, placed in a histological cassette and 
fixed in formaldehyde solution 10% for 24 hours. 
After the material was processed routinely (automatic 
processor), following the dehydration steps (ethanol), 
diaphanization (xylene), impregnation and paraffin 
embedding, microtome and HE staining technique. 
Histological sections stained with Hematoxylin and 
Eosin were examined as a complementary diagnostic 
tool to US-FNA. 
Two independent pathologists reviewed the 
cytological and histological slides of each case together 
and a final diagnostic category was assigned to cyto and 
cyto-cell block. The adequacy of cytological aspirates 
was defined according to the recommendations of the 
Papanicolaou Society of Cytopathology Task Force on 
Standards of Practice, 1996 (13) and cytological results 
classified according to the criteria of the Bethesda System 
for Cytological Classification of Thyroid Nodu les into 6 
diagnostic categories: 1) Non-diagnosis or Unsatisfactory, 
2) Benign, 3) Atypia of undetermined significance; 4) 
Follicular neoplasm or suspicious for follicular neoplasm; 
5) Suspicious for malignancy and 6) Malignant.
Cell-block slides were reviewed for the presence of 
cellular elements and classified into two categories: 1) 
diagnostic and 2) non diagnostic. 
US-FNA cytology and cell block results were 
validated in a subgroup of 75 patients who underwent 
lobectomy or thyroidectomy at our hospital and 
the surgical specimens examined at the Pathology 
Laboratory. The cytological and cyto-cell block results 
were classified as 1) false-negative for malignancy. 2) 
false-positive for malignancy, 3) true positive and 4) 
true negative. True-negatives were Bethesda Class II 
cytology cases with benign pathology reports. True 
positives were suspicious for malignancy (Bethesda 
Class V) and malignant (Bethesda Class VI) confirmed 
malignant by the final pathology report. 
Statistical analysis of the results was performed with 
SPSS software (Statistical Package for Social Sciences) 
version 18.0 and based on frequency data and mean 
± standard deviation (SD). To evaluate the diagnostic 
accuracy of US-FNA, the rates of sensitivity, specificity, 
negative predictive value and positive predictive value 
were calculated (14). P value was considered statistically 
significant for values less than 5% (p < 0.05).
The project was approved by the Research Ethics 
Committee of the Hospital de Clínicas de Porto Alegre 
(GPPG 140538).
RESULTS
Patients
A total of 358 patients with thyroid nodules underwent 
US-FNA procedure. Of them, 328 (91.6%) had their 
samples analyzed by both cyto and cyto-cell while 30 
samples (8.3%) were analyzed only by cytology. Thus 
the study population consisted of 328 consecutive 
patients (291 females, 88.7%). Mean age was 57.4 ± 
13.7 years and the mean size of the nodules was 2.31 ± 
1.22 cm. No significant differences were observed on 
gender (90% females), mean age (50.3 ± 14.8 years) or 
nodular size (2.09 ± 0.87 cm) between patients who 
had cell block and those who not (all P > 0.10).
Cytology and cell block
The cytological results were as follows: 17.1% (n = 56) 
classified as Bethesda I; 61.6% (n = 202), Bethesda II; 
9.5% (n = 31), Bethesda III; 5.8% (n = 19), Bethesda 
IV; 2.4% (n = 8), Bethesda V and 3.6% (n = 12) 
Bethesda VI. 
Cell blocks were obtained in 328 cases and were 
considered diagnostic in 89.6% and not diagnostic 
(unsatisfactory) in 34 cases (10.4%). The combined 
cytological and cell block (cyto-cell) interpretations 
were as follows: 4.3% (n = 14) unsatisfactory, 72.6% 
(n = 238) benign, 11.3% (n = 37) indeterminate, 5.8% 
(n = 19) follicular lesion, 2.4% (n = 8) suspicious for 
malignancy and 3.6% (n = 12) malignant (Table 1). 
The comparison of unsatisfactory ratios between the 
two techniques, US-FNA cytology and cyto-cell block, 
showed a significant reduction in the unsatisfactory 
rate (17.1% vs. 4.3%, p < 0.001). Illustrative cases 
of combined cytological, cell block and US results 
classified as benign and malignant are observed in 
Figures 1 and 2, respectively.  
Cyto-cell block and histological follow-up
Seventy-five out of 328 (22.8%) patients underwent 
surgery and the anatomopathology report was 
considered as the gold standard diagnosis. All patients 
had cytological and cell block reports. The results are 
shown in Table 1. Three patients included in category 
I (unsatisfactory) were diagnosed as multinodular 
goiter (MNG). Twenty-one patients classified as 
class II had benign findings in the surgical pathology 
report (17 MNG, 1 thyroiditis, 1 follicular adenoma, 1 
nodular hyperplasia); papillary thyroid microcarcinoma 
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(PTMC) was found incidentally in 1 case. The patients 
classified as class V had 2 MNG and 7 papillary thyroid 
carcinoma (PTC) whereas patients classified in category 
VI had 1 medullary thyroid carcinoma (MTC) and 8 
PTCs.
Overall, the number of cases that had their final 
diagnosis changed after cell block analysis was 44/328 
(13.4%). The majority of cases belonged to the 
Bethesda I category (40/44 or 91%) and was changed 
to a Bethesda II, or less frequently, to a Bethesda III 
category. The remaining cases (3/44 or 6.8%) were 
Bethesda II that changed to Bethesda III or the reverse. 
Just one Bethesda II case in cytology has become 
Bethesda VI after the analysis of the cell block (Table 2). 
The surgery in this case was indicated by the attending 
physician after the cell block analysis showing papillary 
fragments with nuclear atypia and pseudoinclusions, 
suggesting papillary thyroid carcinoma. Subsequently, 
the anatopathogical examination revealed papillary 
carcinoma. 
Cytology/Cyto-cell block Accuracy
Cytology analysis of sensitivity and specificity were 
calculated considering 35 cases for analysis. The 
calculated sensitivity and specificity on cytology was 
93% (15/16) and 89% (17/19), respectively. The 
analysis of positive predictive value and negative 
predictive value revealed, respectively, 88% and 
94%. The accuracy was 91% (32/35) (Table 3). The 
results included 2 false-positives for malignancy, 1 
false-negative, 15 truly positive and 17 truly negative 
cases. Cases excluded from the analysis of sensitivity 
and specificity were as follows: 9 unsatisfactory cases 
(class I), 13 indeterminate cases (class III), 16 follicular 
lesions (class IV) and 2 PTMCs detected incidentally. 
PTMC was classified as ‘‘incidental’’ when it was found 
at histological examination after thyroid surgery. 
When these parameters were calculated considering 
the combined use of cyto-cell block the results were 
as follows: the sensitivity and specificity calculated 
were 100% (16/16) and 90% (20/22), respectively. 
The analysis of positive predictive value and negative 
predictive value revealed, respectively, 88% and 100%. 
The accuracy was 94% (36/38). The results included 2 
false-positives for malignancy, 0 false-negative, 16 truly 
positive and 20 truly negative cases. Cases excluded from 
the analysis of sensitivity and specificity were as follows: 
3 unsatisfactory cases (class I), 15 indeterminate cases 
(class III), 16 follicular lesion (class IV) and 3 PTMCs 
(Table 3).
Table 1. Distribution of the diagnostic categories in 328 patients and 75 cases operated
Diagnoses Cytology N (%) Cyto-cell block N (%) Final histology
Unsatisfactory (non diagnostic) 56 (17.1) 14 (4.3) 3 MNG
Benign follicular nodule/thyroiditis 202 (61.6) 238 (72.6) 17 MNG, 1 thyroiditis, 1 follicular adenoma, 1 nodular hyperplasia and 1 PTMC
Atypical features 31 (9.5) 37 (11.3) 9 MNG, 1 thyroiditis, 2 follicular adenomas, 1 nodular hyperplasias,  
1 Hürthle cell adenoma, 1 PTC and 1 PTMC
Follicular lesions 19 (5.8) 19 (5.8) 7 MNG, 5 follicular adenomas, 1 nodular hyperplasia, 3 Hürthle cell carcinomas 
and 1 PTMC
Suspicious for malignancy 8 (2.4) 8 (2.4) 2 MNG and 7 PTCs
Malignant 12 (3.6) 12 (3.6) 1 MTC and 8 PTCs
Total 328 328 75
MNG: multinodular colloid goiters; PTC: papillary thyroid carcinoma; PTMC: papillary thyroid microcarcinoma; MTC: medullary thyroid carcinoma.
Table 2. Samples with diagnosis changed after cell block analysis
Number of cases (N = 44)
 N (%)
Cytology
(Bethesda System) Cyto-cell block
36 (81%) I Benign
4 (9%) I Atypical Features
2 (4.5%) II Atypical Features
1 (2.2%) III Benign
1 (2.2%) II Malignant
Table 3. The predictive values of cytology and combined cyto-cell block 
results
Cytology Cyto-cell block
Sensitivity 93% 100%
Specificity 89% 90%
PPV* 88% 88%
NPV** 94% 100%
Accuracy 91% 94%
* PPV: positive predictive value; ** NPV: negative predictive value.
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Figure 2. Papillary Thyroid Carcinoma (Bethesda VI). A and B: Monolayer 
sheets of atypical cells with a syncytial-like appearance and dense 
cytoplasm. Nuclear grooves are not conspicuous in air-dried preparations 
(smear, May Grünwald-Giemsa, 400X). C: Follicular fragments with 
nuclear pseudoinclusions (cell block, H&E stain, 400X). D: US image 
showing an irregular hypoechoic nodule with microcalcifications.
Figure 1. Benign follicular nodule (Bethesda II). A and B: Typical follicular 
cells containing green-black cytoplasmic granules and vacuolated 
macrophage (smear, May Grünwald-Giemsa, 400X). C: Follicular fragment 
showing hyperplastic architecture (cell block, H&E stain, 200X). D: US 
image of an isoechoic benign nodule with regular margins and no 
microcalcifications.
DISCUSSION
Here we further demonstrated the importance of 
US-FNA in the management of thyroid nodules. 
Additionally, we show that using cell block as a 
complementary diagnostic tool improves the efficiency 
of this technique. The overall accuracy of cyto-cell block 
for detection of neoplasm was 94%, with a sensibility 
and specificity of 100% and 90%, respectively.
Thyroid  nodules are a significant clinical problem 
in the general population but the majority of them 
are benign and do not require surgery (15). Indeed, 
the prevalence of thyroid carcinomas is approximately 
4%. The main gains from implementation of US-
FNA include a reduction in the number of outpatient 
clinic attendances and hospital inpatient stays, with a 
consequent reduction in leave of absence from work. 
A faster diagnosis should also reduce patient anxiety 
(16). A reduction in operative rates for thyroid nodules 
would also produce a lower population rate of thyroid 
surgery-related morbidity (17). In agreement with 
the literature, we found that 6% of cases that were 
malignant or suspicious for malignancy (5,18). 
One of the limitations of cytological analysis 
obtained by US-FNA is the relative high rate of 
unsatisfactory samples (5-30%), due to limited material 
available for adjunctive diagnostic investigations. 
Cellularity in cytological samples is an item to be 
considered, because often the limited representativeness 
of the sample determines the failure diagnosis. The 
difficulties to obtain satisfactory samples are inherent 
to the procedure and are consistent with the literature. 
Very fibrous nodules, cysts or necrotic lesions generally 
provide a very small number of viable cells for diagnosis 
(5,9,19). 
In this context, the cell block technique allows 
recovery of small tissue fragments in a fluid sample which 
is processed to form a paraffin block. It has been widely 
accepted that this method of analysis increases the cell 
yield, providing a larger amount of material for analysis 
and improves diagnostic accuracy (12,20,21). However, 
the success of the cell block technique involves care and 
must meet certain requirements: maintenance of cell 
morphology and tissue architecture; optimization of 
the processing time without loss of quality material and 
obtaining sufficient reserve of material for further testing 
and immunohistochemical reactions (10). In this study, 
comparing the unsatisfactory rates, we can observe that 
the addition of the cell block to the US-FNA cytological 
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technique significantly reduced the rate of unsatisfactory 
samples (17.1% vs. 4.3%, P < 0.001). 
The embedded cytological sample in paraffin, with 
further processing, like a histological sample mimics 
the cell arrangement and the architectural features in 
the tissue, thus contributing to the diagnosis. Thus, 
it is disappointing that we find only few reports in 
the literature on the application of the cell block 
method to hospital routines. Our results show that the 
combination of the cell block and US-FNA techniques 
improved representativeness of the samples and a gain 
in diagnosis, since this methodology contributed to the 
increased cellularity and morphological details as groups 
with papillary and three-dimensional arrangement, 
cytoplasmic and nuclear preservation (22-24).
The number of insufficient/not diagnostic cases 
reached 4% in our series and indeterminate cytology was 
around 11%. These low percentages emphasize the US 
role in reducing the percentage of insufficient material 
or inappropriate diagnosis. These good results are due 
mainly to the guided choice of the nodule region to 
be aspirated, especially in the case of mixed nodules. 
The validated sensitivity (100%) and specificity (90%) of 
the diagnostic method were considered adequate. The 
accuracy (94%) of the procedure was considered high. 
The major contribution of cell block analysis to 
FNA cytology in the present study was to decrease 
the rate of unsatisfactory specimen. Likewise, only a 
benign case in cytology change to malignant category 
after analysis of the cell block. Therefore, cell block 
preparation may change patient management like 
avoiding repeated FNA or unnecessary surgeries, once 
most of the benefit came from moving cases from the 
unsatisfactory category to the benign group.
In conclusion, US-FNA is a powerful diagnostic tool 
for the diagnosis of thyroid nodules and can effectively 
reduce unnecessary surgeries. The combination of 
techniques, cytology and cell block, has increased 
the representativeness of the samples and lower false 
negative rates. The main advantage of cell block 
technique is to concentrate the cells in a limited field, 
without loss of material for analysis and it can be used 
routinely. There is also the possibility of implementing 
special staining immunohistochemistry when needed.
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technique significantly reduced the rate of unsatisfactory 
samples (17.1% vs. 4.3%, P < 0.001). 
The embedded cytological sample in paraffin, with 
further processing, like a histological sample mimics 
the cell arrangement and the architectural features in 
the tissue, thus contributing to the diagnosis. Thus, 
it is disappointing that we find only few reports in 
the literature on the application of the cell block 
method to hospital routines. Our results show that the 
combination of the cell block and US-FNA techniques 
improved representativeness of the samples and a gain 
in diagnosis, since this methodology contributed to the 
increased cellularity and morphological details as groups 
with papillary and three-dimensional arrangement, 
cytoplasmic and nuclear preservation (22-24).
The number of insufficient/not diagnostic cases 
reached 4% in our series and indeterminate cytology was 
around 11%. These low percentages emphasize the US 
role in reducing the percentage of insufficient material 
or inappropriate diagnosis. These good results are due 
mainly to the guided choice of the nodule region to 
be aspirated, especially in the case of mixed nodules. 
The validated sensitivity (100%) and specificity (90%) of 
the diagnostic method were considered adequate. The 
accuracy (94%) of the procedure was considered high. 
The major contribution of cell block analysis to 
FNA cytology in the present study was to decrease 
the rate of unsatisfactory specimen. Likewise, only a 
benign case in cytology change to malignant category 
after analysis of the cell block. Therefore, cell block 
preparation may change patient management like 
avoiding repeated FNA or unnecessary surgeries, once 
most of the benefit came from moving cases from the 
unsatisfactory category to the benign group.
In conclusion, US-FNA is a powerful diagnostic tool 
for the diagnosis of thyroid nodules and can effectively 
reduce unnecessary surgeries. The combination of 
techniques, cytology and cell block, has increased 
the representativeness of the samples and lower false 
negative rates. The main advantage of cell block 
technique is to concentrate the cells in a limited field, 
without loss of material for analysis and it can be used 
routinely. There is also the possibility of implementing 
special staining immunohistochemistry when needed.
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